Lab-Grown Blood Donated to Human Patients for the First Time

Scientists have successfully transfused lab-grown blood into human patients for the first time in history. This major medical milestone could eventually eliminate global blood shortages and provide a perfect match for patients with ultra-rare blood types. By turning stem cells into fresh red blood cells, researchers are fundamentally changing modern medicine.

The RESTORE Clinical Trial Explained

The breakthrough is part of a clinical trial known as RESTORE. The project is a joint effort in the United Kingdom involving researchers from NHS Blood and Transplant, the University of Bristol, and the University of Cambridge. Their goal is to test the safety and lifespan of manufactured red blood cells inside the human body.

During the initial phase of the trial, two healthy volunteers received the first ever transfusions of lab-grown blood. The researchers did not give them full bags of blood. Instead, the patients received micro-doses of 5 to 10 milliliters. This equals about one to two teaspoons of liquid. By starting with a tiny amount, the medical team could monitor the volunteers for adverse immune reactions while safely tracking how the artificial cells behaved.

How Scientists Grow Blood in a Laboratory

Creating blood outside of the human body is a highly complex process that takes about three weeks from start to finish. The process does not eliminate the need for human donors just yet. The scientists still need a standard pint of donated blood to kick off the manufacturing process.

Here is exactly how the researchers create the blood:

• Stem Cell Extraction: Scientists take a standard blood donation and use microscopic magnetic beads to fish out flexible stem cells capable of turning into red blood cells.
• Culturing: They place these isolated stem cells in a nutrient-rich solution inside a laboratory incubator.
• Multiplication: Over the course of 21 days, the cells multiply rapidly. A starting pool of half a million stem cells grows into roughly 50 billion red blood cells.
• Filtering: Because not all of these cells mature properly, the team filters the batch to extract about 15 billion healthy, fully developed red blood cells ready for a patient.

The Shelf-Life Advantage of Manufactured Blood

One of the most exciting aspects of lab-grown blood is its potential longevity. A standard red blood cell lives for roughly 120 days inside the human body before it naturally breaks down and needs to be replaced.

When a person receives a traditional blood transfusion from a human donor, the bag contains a random mixture of young and old blood cells. Some of those cells might be 110 days old and will die off in just over a week. Lab-grown blood is entirely different. Because the cells are freshly grown in an incubator, every single cell in the bag is brand new.

To prove this, researchers in the RESTORE trial tagged the lab-grown cells with a mildly radioactive medical tracer. This tracer allows doctors to track the exact lifespan of the blood inside the volunteers. If the manufactured blood lasts the full 120 days, patients who require frequent transfusions will not need to visit the hospital nearly as often.

Why Lab-Grown Blood Matters for Rare Conditions

While the average person might never need manufactured blood, this scientific leap is life-changing for people with specific blood disorders. Patients with sickle cell disease or thalassemia require regular blood transfusions to survive.

When a patient receives blood from multiple different donors over several years, their immune system starts to notice microscopic differences in the donated cells. The body eventually creates antibodies against these foreign cells. Once a patient develops these antibodies, finding a compatible human donor becomes incredibly difficult. Blood banks struggle to find exact genetic matches for rare groups like the Bombay blood type.

By growing blood in a lab, doctors can carefully match the exact genetic profile needed for these patients. The lab-grown blood provides a pure, custom-made lifeline that the patient’s immune system will accept without a fight.

Roadblocks to Mass Production

Despite the incredible success of the RESTORE trial, you will not see lab-grown blood in standard emergency rooms anytime soon. The technology faces massive financial and logistical hurdles.

First, the process is incredibly expensive. Growing billions of cells in controlled incubators requires specialized equipment and costly nutrient solutions. Second, the current yield is quite small. Turning a standard donation into a usable volume of pure red blood cells is highly inefficient right now. Scientists must figure out how to scale up the technology so they can produce hundreds of liters of blood at a fraction of the current cost.

Frequently Asked Questions

Is lab-grown blood completely artificial?

No. The blood is grown from real human stem cells taken from standard volunteer blood donations. The cells themselves are natural biological structures, but they are multiplied and matured in a laboratory environment instead of bone marrow.

Will manufactured blood replace human blood donations?

Human blood donors will still be needed for the foreseeable future. Standard blood donations are cheaper and easier to collect for routine surgeries and emergency trauma care. Lab-grown blood will strictly be reserved for patients with ultra-rare blood types or complex medical conditions.

Is the lab-grown blood safe for patients?

So far, the results of the RESTORE trial show no adverse side effects. The volunteers tolerated the 10-milliliter micro-doses perfectly. Ongoing trials will test larger volumes to ensure the cells remain safe in greater quantities.